Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 23451354)

1.

Reply to A. Levy et al.

Jain RK, Lee JJ, Hong D, Kurzrock R.

J Clin Oncol. 2013 Jan 20;31(3):396. No abstract available.

2.

Tumor assessment criteria in phase I trials: beyond RECIST.

Levy A, Hollebecque A, Ferté C, Koscielny S, Fernandez M, Soria JC, Massard C.

J Clin Oncol. 2013 Jan 20;31(3):395. doi: 10.1200/JCO.2012.46.2184. Epub 2012 Dec 17. No abstract available.

3.

Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies.

Jain RK, Lee JJ, Ng C, Hong D, Gong J, Naing A, Wheler J, Kurzrock R.

J Clin Oncol. 2012 Jul 20;30(21):2684-90. doi: 10.1200/JCO.2011.36.4752. Epub 2012 Jun 11.

4.

Rules of thumb for maximum percent tumor accumulation.

Liu G.

Nucl Med Biol. 2013 Aug;40(6):865-7. doi: 10.1016/j.nucmedbio.2013.04.010. Epub 2013 Jun 18. No abstract available.

5.

Re: E. Jason Abel, Stephen H. Culp, Nizar M. Tannir, et al. Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol 2011;59:10-5.

Ozcan MF, Canda AE, Dizdar O, Altinova S, Akbulut Z, Balbay MD.

Eur Urol. 2011 Jun;59(6):e34. doi: 10.1016/j.eururo.2011.02.038. Epub 2011 Mar 12. No abstract available.

PMID:
21398023
6.

[Surgery after. . .].

Évrard S.

Bull Cancer. 2011 Jan;98(1):8-9. French. No abstract available.

PMID:
21591297
7.

The role of targeted therapy in ovarian cancer.

Banerjee S, Kaye S.

Eur J Cancer. 2011 Sep;47 Suppl 3:S116-30. doi: 10.1016/S0959-8049(11)70155-1. Review.

PMID:
21943965
8.

[Molecular targeted anticancer agents in the First in Human study--possibility for dosing healthy volunteers].

Kato R.

Nihon Yakurigaku Zasshi. 2012 Sep;140(3):131-4. Review. Japanese. No abstract available.

PMID:
22975828
9.

Optimal assessment of response in ovarian cancer.

Eisenhauer EA.

Ann Oncol. 2011 Dec;22 Suppl 8:viii49-viii51. doi: 10.1093/annonc/mdr467.

10.

The inverted pyramid of biomarker-driven trials.

Garrido-Laguna I, Hidalgo M, Kurzrock R.

Nat Rev Clin Oncol. 2011 Aug 2;8(9):562-6. doi: 10.1038/nrclinonc.2011.113.

PMID:
21808269
11.

Tumor response evaluation in oncology: current update.

Shanbhogue AK, Karnad AB, Prasad SR.

J Comput Assist Tomogr. 2010 Jul;34(4):479-84. doi: 10.1097/RCT.0b013e3181db2670. Review.

PMID:
20657213
12.

The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.

Ataman OU, Sambrook SJ, Wilks C, Lloyd A, Taylor AE, Wedge SR.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e447-54. doi: 10.1016/j.ijrobp.2012.05.019. Epub 2012 Jul 20. Review.

PMID:
22819210
13.

Personalized-medicine trials on the rise.

Benowitz S.

J Natl Cancer Inst. 2012 Oct 3;104(19):1425-6. doi: 10.1093/jnci/djs432. Epub 2012 Sep 24. No abstract available.

14.

[Recent proposals for early stage clinical trials of cancer].

Ohashi Y.

Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:292-4. Review. Japanese.

PMID:
7986106
15.

Is tumor response important for renal carcinoma?

Inman BA, George DJ.

Eur Urol. 2011 Jan;59(1):16-7. doi: 10.1016/j.eururo.2010.10.010. Epub 2010 Oct 15. No abstract available.

PMID:
20970245
16.

Drug approvals 2011: focus on companion diagnostics.

Goozner M.

J Natl Cancer Inst. 2012 Jan 18;104(2):84-6. doi: 10.1093/jnci/djr552. Epub 2012 Jan 3. No abstract available.

17.

Reply to D.M. Hyman et al and M. Voskoboynik et al.

Ballman KV.

J Clin Oncol. 2014 Oct 1;32(28):3200. doi: 10.1200/JCO.2014.56.5770. Epub 2014 Jul 28. No abstract available.

PMID:
25071106
18.

Review on clinical trials of targeted treatments in malignant mesothelioma.

Jakobsen JN, Sørensen JB.

Cancer Chemother Pharmacol. 2011 Jul;68(1):1-15. doi: 10.1007/s00280-011-1655-3. Epub 2011 May 7. Review.

PMID:
21553148
19.
20.

An (only) partially established paradigm of drug development of targeted therapies.

Rodon J.

Eur J Cancer. 2014 Aug;50(12):2037-9. doi: 10.1016/j.ejca.2014.04.029. Epub 2014 Jun 4. No abstract available.

PMID:
24908539
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk